Kasper DL - Search Results

1

Cellular and humoral immunity are synergistic in protection against types A and B Francisella tularensis.

Sebastian S, Pinkham JT, Lynch JG, Ross RA, Reinap B, Blalock LT, Conlan JW, Kasper DL. Sebastian S, et al. Among authors: kasper dl. Vaccine. 2009 Jan 22;27(4):597-605. doi: 10.1016/j.vaccine.2008.10.079. Epub 2008 Nov 18. Vaccine. 2009. PMID: 19022323 Free PMC article.

2

Synthesis and preclinical evaluation of glycoconjugate vaccines against group B Streptococcus types VI and VIII.

Paoletti LC, Pinel J, Johnson KD, Reinap B, Ross RA, Kasper DL. Paoletti LC, et al. Among authors: kasper dl. J Infect Dis. 1999 Sep;180(3):892-5. doi: 10.1086/314955. J Infect Dis. 1999. PMID: 10438388

3

Construction of designer glycoconjugate vaccines with size-specific oligosaccharide antigens and site-controlled coupling.

Wang JY, Chang AH, Guttormsen HK, Rosas AL, Kasper DL. Wang JY, et al. Among authors: kasper dl. Vaccine. 2003 Mar 7;21(11-12):1112-7. doi: 10.1016/s0264-410x(02)00625-4. Vaccine. 2003. PMID: 12559788

4

A defined O-antigen polysaccharide mutant of Francisella tularensis live vaccine strain has attenuated virulence while retaining its protective capacity.

Sebastian S, Dillon ST, Lynch JG, Blalock LT, Balon E, Lee KT, Comstock LE, Conlan JW, Rubin EJ, Tzianabos AO, Kasper DL. Sebastian S, et al. Among authors: kasper dl. Infect Immun. 2007 May;75(5):2591-602. doi: 10.1128/IAI.01789-06. Epub 2007 Feb 12. Infect Immun. 2007. PMID: 17296751 Free PMC article.

5

Small molecule control of virulence gene expression in Francisella tularensis.

Charity JC, Blalock LT, Costante-Hamm MM, Kasper DL, Dove SL. Charity JC, et al. Among authors: kasper dl. PLoS Pathog. 2009 Oct;5(10):e1000641. doi: 10.1371/journal.ppat.1000641. Epub 2009 Oct 30. PLoS Pathog. 2009. PMID: 19876386 Free PMC article.

6

Characterization of the O-antigen polymerase (Wzy) of Francisella tularensis.

Kim TH, Sebastian S, Pinkham JT, Ross RA, Blalock LT, Kasper DL. Kim TH, et al. Among authors: kasper dl. J Biol Chem. 2010 Sep 3;285(36):27839-49. doi: 10.1074/jbc.M110.143859. Epub 2010 Jul 6. J Biol Chem. 2010. PMID: 20605777 Free PMC article.

7

3-Deoxy-D-manno-octulosonic acid (Kdo) hydrolase identified in Francisella tularensis, Helicobacter pylori, and Legionella pneumophila.

Chalabaev S, Kim TH, Ross R, Derian A, Kasper DL. Chalabaev S, et al. Among authors: kasper dl. J Biol Chem. 2010 Nov 5;285(45):34330-6. doi: 10.1074/jbc.M110.166314. Epub 2010 Aug 26. J Biol Chem. 2010. PMID: 20801884 Free PMC article.

8

Sensitivity of Francisella tularensis to ultrapure water and deoxycholate: implications for bacterial intracellular growth assay in macrophages.

Chalabaev S, Anderson CA, Onderdonk AB, Kasper DL. Chalabaev S, et al. Among authors: kasper dl. J Microbiol Methods. 2011 Jun;85(3):230-2. doi: 10.1016/j.mimet.2011.03.006. Epub 2011 Mar 21. J Microbiol Methods. 2011. PMID: 21420447 Free PMC article.

9

Genetic modification of the O-polysaccharide of Francisella tularensis results in an avirulent live attenuated vaccine.

Kim TH, Pinkham JT, Heninger SJ, Chalabaev S, Kasper DL. Kim TH, et al. Among authors: kasper dl. J Infect Dis. 2012 Apr 1;205(7):1056-65. doi: 10.1093/infdis/jir620. Epub 2011 Oct 3. J Infect Dis. 2012. PMID: 21969334 Free PMC article.

10

Kdo hydrolase is required for Francisella tularensis virulence and evasion of TLR2-mediated innate immunity.

Okan NA, Chalabaev S, Kim TH, Fink A, Ross RA, Kasper DL. Okan NA, et al. Among authors: kasper dl. mBio. 2013 Feb 12;4(1):e00638-12. doi: 10.1128/mBio.00638-12. mBio. 2013. PMID: 23404403 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

353 results

Search Page